|
PACRGL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.851600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.806600E-01 |
| Normal-vs-Stage2 |
5.477200E-01 |
| Normal-vs-Stage3 |
5.520400E-02 |
| Normal-vs-Stage4 |
7.203000E-01 |
| Stage1-vs-Stage2 |
9.551000E-01 |
| Stage1-vs-Stage3 |
1.993210E-01 |
| Stage1-vs-Stage4 |
4.643200E-01 |
| Stage2-vs-Stage3 |
4.036600E-01 |
| Stage2-vs-Stage4 |
5.198000E-01 |
| Stage3-vs-Stage4 |
1.320380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.207600E-01 |
| Normal-vs-AfricanAmerican |
2.042000E-01 |
| Normal-vs-Asian |
2.044000E-02 |
| Caucasian-vs-AfricanAmerican |
4.838200E-01 |
| Caucasian-vs-Asian |
2.118300E-02 |
| AfricanAmerican-vs-Asian |
2.865200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.949230E-01 |
| Normal-vs-Female |
8.060600E-01 |
| Male-vs-Female |
3.484800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.734430E-01 |
| Normal-vs-Extreme_Weight |
1.313990E-01 |
| Normal-vs-Obese |
9.613200E-01 |
| Normal-vs-Extreme_Obese |
5.031800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.492200E-01 |
| Normal_Weight-vs-Obese |
2.217600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.491200E-01 |
| Extreme_Weight-vs-Obese |
2.027800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.701800E-01 |
| Obese-vs-Extreme_Obese |
2.231800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.447400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.755000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.860840E-01 |
| Normal-vs-Age(81-100Yrs) |
1.572390E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.191800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.371400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.864400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.438000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.966500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.316400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.246600E-01 |
| Normal-VS-Type2 PRCC |
1.550230E-02 |
| Normal-VS-KIRP CIMP |
7.008400E-02 |
| Normal-VS-Unclassified PRCC |
6.592400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.321000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.774970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.767000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.210800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.403380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.143000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.559100E-04 |
| Normal-vs-N1 |
5.365800E-01 |
| Normal-vs-N2 |
1.585980E-01 |
| N0-vs-N1 |
1.487020E-01 |
| N0-vs-N2 |
9.881600E-01 |
| N1-vs-N2 |
5.488800E-01 |
|
|
